Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Testicular cancer Stories

2005-08-23 07:46:39

By Patrick Vignal PARIS (Reuters) - Seven-times Tour de France winner Lance Armstrong has denied ever taking performance-enhancing drugs following a report in French newspaper L'Equipe that he used the blood-boosting drug EPO in 1999. Tour de France executive director Jean-Marie Leblanc said he felt let down by Armstrong after L'Equipe alleged the American had used the banned drug in 1999, the year he first won the world's greatest cycle race. Armstrong, who recovered from...

2005-07-22 20:27:29

NEW YORK (Reuters Health) - After surgery, a single dose of carboplatin appears to be just as effective in preventing relapse as three weeks of radiation therapy in men with early-stage testicular cancer, according to the findings of a study published in this week's issue of The Lancet. Carboplatin also appears to be associated with less severe adverse effects and lower risk of developing a tumor in the other testicle. Although radiotherapy has long been the accepted treatment approach,...

2005-07-19 13:03:41

By Patricia Reaney LONDON (Reuters) - Most testicular cancer patients who try to father children after completing their treatment succeed, scientists said Tuesday. Men who have surgery to remove the tumour have the least problems but even patients who have radiotherapy and chemotherapy are able to have children. "The vast majority of men, after testicular cancer treatment, can go on and have a family as normal," said Dr Robert Huddart of The Institute of Cancer Research in London. But he...

8ea577b72ac9dabebf653012481d443a1
2005-06-30 08:06:15

NEW YORK (Reuters Health) -- Though testicular cancer remains relatively uncommon, rates of the disease have risen in many countries since the 1970s, a new study shows. Testicular cancer is known to be most common among white men, and worldwide, rates of the disease are still highest in the U.S., Canada, Australia and Europe -- particularly in Nordic countries such as Denmark and Norway. But researchers at National Cancer Institute in Bethesda, Maryland, have found that rates of the disease...